Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $384000.0.

  • Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF) fell 375.94% to $384000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 1896.46%. This contributed to the annual value of $1.7 million for FY2024, which is 2759.5% down from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Depreciation & Amortization (CF) of $384000.0 as of Q3 2025, which was down 375.94% from $358000.0 recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Depreciation & Amortization (CF) high stood at $717000.0 for Q2 2021, and its period low was $312000.0 during Q1 2021.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF) had a median value of $540000.0 in 2023 and averaged $520000.0.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 11025.64% in 2022, then plummeted by 3383.08% in 2024.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Depreciation & Amortization (CF) stood at $668000.0 in 2021, then dropped by 9.88% to $602000.0 in 2022, then dropped by 10.3% to $540000.0 in 2023, then decreased by 25.93% to $400000.0 in 2024, then decreased by 4.0% to $384000.0 in 2025.
  • Its Depreciation & Amortization (CF) was $384000.0 in Q3 2025, compared to $358000.0 in Q2 2025 and $345000.0 in Q1 2025.